	US 11,833,123 B2
	Pharmaceutical composition
Ayaka Matsuoka, Ibaraki (JP)
Assigned to Kobayashi Pharmaceutical Co., Ltd., Osaka (JP)
Appl. No. 17/278,170
Filed by KOBAYASHI PHARMACEUTICAL CO., LTD., Osaka (JP)
PCT Filed Sep. 2, 2019, PCT No. PCT/JP2019/034488 § 371(c)(1), (2) Date Mar. 19, 2021, PCT Pub. No. WO2020/059474, PCT Pub. Date Mar. 26, 2020.
Claims priority of application No. 2018-177431 (JP), filed on Sep. 21, 2018.
Prior Publication US 2021/0346323 A1, Nov. 11, 2021
Int. Cl. A61K 31/167 (2006.01); A61J 1/14 (2023.01)

CPC A61K 31/167 (2013.01) [A61J 1/1468 (2015.05)]

5 Claims

1. A pharmaceutical composition, comprising:

lidocaine and/or a salt thereof,

wherein the pharmaceutical composition is placed in a container in which an inner wall is composed of linear low-density polyethylene, and the linear low-density polyethylene has a side chain having a carbon number of 4 or less.